Dynavax Technologies
DVAX
#4995
Rank
C$2.47 B
Marketcap
C$21.12
Share price
0.00%
Change (1 day)
8.99%
Change (1 year)

Dynavax Technologies (DVAX) - Total debt

Total debt on the balance sheet as of September 2025 : C$0.38 Billion

According to Dynavax Technologies 's latest financial reports the company's total debt is C$0.38 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Dynavax Technologies - Total debt on balance sheet (from 2009 to 2025)

Total debt by year

Year Total debt Change
2024-12-31C$0.36 B7.14%
2023-12-31C$0.34 B-2.67%
2022-12-31C$0.35 B6.73%
2021-12-31C$0.32 B18.09%
2020-12-31C$0.27 B-1.74%
2019-12-31C$0.28 B105.73%
2018-12-31C$0.13 B
2014-12-31C$11.09 M
2012-12-31N/A-100%
2011-12-31C$13.03 M10.64%
2010-12-31C$11.77 M-9.6%
2009-12-31C$13.02 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Pfizer
PFE
C$87.14 B 22,340.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$74.39 B 19,057.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$8.96 B 2,207.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C$33.97 B 8,648.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$67.21 B 17,210.47%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$39.71 B 10,126.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
C$32.51 B 8,272.59%๐Ÿ‡ฌ๐Ÿ‡ง UK
Agenus
AGEN
C$62.35 M-83.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$23.28 B 5,897.39%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel